Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar. (2024). Medical Forum Monthly, 26(3). https://medicalforummonthly.com/index.php/mfm/article/view/2736